Finance

Lists
VTR:NYSE
Ventas Inc
US$ ८४.३१
+०.५६%
(+०.४७) 1D
US$ ८४.३१
०.००% (०.००)
After hours
Closed: अक्टोबर १४, १६:०२:२८ GMT-४  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for VTR...
Open
US$ ८४.१८
High
US$ ८५.४०
Low
US$ ८३.२६
Mkt. cap
४३.२५ अरब
Avg. vol.
३९.३४ लाख
Volume
३९.४३ लाख
Dividend
२.४२%
Quarterly dividend
US$ ०.५१
Ex-dividend date
२०२६ सेप्टेम्बर ३०
P/E ratio
१५४.६८
52-wk high
US$ १०१.६०
52-wk low
US$ ६७.८०
EPS
US$ ०.५५
Beta
०.७१
Shares outstanding
५१.२९ करोड
No. of employees
५४२
Open
US$ ८४.१८
High
US$ ८५.४०
Low
US$ ८३.२६
Mkt. cap
४३.२५ अरब
Avg. vol.
३९.३४ लाख
Volume
३९.४३ लाख
Dividend
२.४२%
Quarterly dividend
US$ ०.५१
Ex-dividend date
२०२६ सेप्टेम्बर ३०
P/E ratio
१५४.६८
52-wk high
US$ १०१.६०
52-wk low
US$ ६७.८०
EPS
US$ ०.५५
Beta
०.७१
Shares outstanding
५१.२९ करोड
No. of employees
५४२
News stories
From web sources and news partners
Profile
Ventas, Inc. is a real estate investment trust specializing in the ownership and management of research, medicine and healthcare facilities in the United States, Canada and the United Kingdom. As of December 2019, the group's portfolio consisted of 1,200 properties divided among nursing homes, medical office buildings, rehabilitation and acute care centres, special care centres, laboratories and research centres and medical-surgical centres for a total value of nearly $25 billion. As of 2019, it is a Fortune 1000 corporation. Wikipedia
About Ventas Inc
CEODebra Cafaro
Employees५४२
Founded१९८३
Headquartersशिकागो, इलिनोइ, संयुक्त राज्य अमेरिका
SectorReal estate investment trust
Analyst ratings
Based on 15 analysts giving stock ratings to VTR in the past 3 months
Buy
Buy
11
Hold
4
Sell
0
12-month forecast
Based on 15 Wall Street analysts offering 12 month price targets for VTR in the last 3 months.
Highest
Current US$ ८४.३१
US$ ११३.०० (+३४.०३%)
Average
US$ ९९.०० (+१७.४२%)
Lowest
US$ ७२.०० (-१४.६०%)
Analyst
Recommendation
Action
Price target
Projected
Date
Michael Goldsmith
UBS
Hold
Maintained
US$ ९०.००
+६.७%
10/13/2026
Richard Hightower
Barclays
Hold
Maintained
US$ ९१.००
+७.९%
10/13/2026
Juan C. Sanabria
BMO Capital
Buy
Reiterated
US$ १०७.००
+२६.९%
10/02/2026
James Kammert
Evercore ISI
Buy
Maintained
US$ १००.००
+१८.६%
09/21/2026
Julien Blouin
Goldman Sachs
Buy
Maintained
US$ ११२.००
+३२.८%
09/16/2026
Joe Dickstein
Jefferies
Buy
Initiated
US$ १०२.००
+२१%
09/15/2026
Michael Mueller
J.P. Morgan
Buy
Maintained
US$ १०४.००
+२३.४%
09/03/2026
Nicholas Yulico
Scotiabank
Hold
Maintained
US$ ९५.००
+१२.७%
09/02/2026
John Kilichowski
Wells Fargo
Buy
Reiterated
US$ १०४.००
+२३.४%
09/01/2026
Michael Carroll
RBC Capital
Buy
Reiterated
US$ ९९.००
+१७.४%
08/14/2026
Ronald Kamdem
Morgan Stanley
Hold
Reiterated
US$ ९०.००
+६.७%
08/13/2026
Nicholas Joseph
Citi
Buy
Maintained
US$ ७२.००
-१४.६%
08/04/2026
Jeffrey Spector
Bank of America Securities
Buy
Reiterated
US$ ११३.००
+३४%
08/03/2026
Richard Anderson
Cantor Fitzgerald
Buy
Reiterated
US$ १०२.००
+२१%
07/31/2026
Vikram Malhotra
Mizuho Securities
Buy
Maintained
US$ १०४.००
+२३.४%
07/22/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
US$ ११४.००
+३५.२%
07/15/2026
Unknown Analyst
Raymond James
Buy
Initiated
US$ ९४.००
+११.५%
06/16/2026
Dave Rodgers
Raymond James
Buy
Initiated
US$ ९४.००
+११.५%
06/16/2026
Omotayo Okusanya
Deutsche Bank
Buy
Maintained
US$ १००.००
+१८.६%
06/16/2026
Jonathan Petersen
Jefferies
Buy
Maintained
US$ १००.००
+१८.६%
05/12/2026
Austin Wurschmidt
KeyBanc
Buy
Maintained
US$ ९५.००
+१२.७%
05/07/2026
Marie Ferguson
Argus Research
Buy
Maintained
US$ ८८.००
+४.४%
02/09/2026
Next call १३ दिनमा
अक्टोबर २७, मङ्गल, १६:००
Fiscal period
Q3 2026
- / US$ ०.११
Revenue / Est. (USD)
- / १.७८ अरब
Fiscal Q3 2026 earnings call
Waiting for the earnings call
At a glance: upcoming earnings
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
२०२५ सेप्टेम्बर
२०२५ डिसेम्बर
२०२६ मार्च
२०२६ जुन
Revenue
१.५० अरब
१.५५ अरब
१.६५ अरब
१.७२ अरब
Cost of goods sold
८६.९९ करोड
९३.७४ करोड
१.०० अरब
१.०४ अरब
Cost of revenue
८६.९९ करोड
९३.७४ करोड
१.०० अरब
१.०४ अरब
Research and development expenses
-
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
४.०४ करोड
४.१० करोड
६.२७ करोड
४.७० करोड
Operating expense
३९.७६ करोड
२९.७५ करोड
४१.६९ करोड
४२.२७ करोड
Total operating expenses
१.२७ अरब
१.२३ अरब
१.४२ अरब
१.४७ अरब
Operating income
२३.४० करोड
३१.५५ करोड
२२.६८ करोड
२५.४७ करोड
Other non operating income
-१.३४ करोड
-४२.०३ लाख
-९७.०० लाख
-४४.५४ लाख
EBT including unusual items
६.२४ करोड
७.१९ करोड
४.३१ करोड
४.६६ करोड
EBT excluding unusual items
६.६७ करोड
१६.४७ करोड
६.३५ करोड
९.२० करोड
Income tax expense
-६३.४५ लाख
-११.२२ लाख
-१.५९ करोड
-२.५६ करोड
Effective tax rate
-१०.१७%
-१.५६%
-३६.९७%
-५४.९७%
Other operating expenses
-
-
-
-
Net income
६.६० करोड
७.०२ करोड
५.५९ करोड
७.०६ करोड
Net profit margin
४.४०%
४.५३%
३.३९%
४.१०%
Earnings per share
०.१२
०.१३
०.१०
०.१७
Interest and investment income
४१.८४ लाख
७८.७७ लाख
२४.९९ लाख
१७.७८ लाख
Interest expense
-१५.८१ करोड
-१५.४५ करोड
-१५.६१ करोड
-१६.०० करोड
Net interest expenses
-१५.३९ करोड
-१४.६६ करोड
-१५.३६ करोड
-१५.८३ करोड
Depreciation and amortization charges
३५.७२ करोड
२५.६५ करोड
३५.४२ करोड
३७.५७ करोड
EBITDA
५५.९७ करोड
६५.९० करोड
५८.५८ करोड
६३.३६ करोड
Gain or loss from assets sale
-१२.८३ लाख
-३३.११ लाख
-१.५१ करोड
-१.७४ लाख
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more
Google एपहरू